Rajeev Dadoo
CIK: 0001951685
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SPRY
ARS Pharmaceuticals, Inc.
Director
Discretionary Trading P&L
Holdings
About Dadoo Rajeev
Dadoo Rajeev (SEC CIK 0001951685) files insider reports with the SEC as Director of ARS Pharmaceuticals, Inc. (SPRY).
Signal8 holds 2 ownership filings by Dadoo Rajeev, all Form 4s, filed between Jun 27, 2025 and Jun 26, 2026. Those filings report 2 transactions, from Jun 25, 2025 to Jun 24, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Dadoo Rajeev's filings is in REDWOOD CITY, CA.
Recent filings by Dadoo Rajeev
Other insiders filing for ARS Pharmaceuticals, Inc. (SPRY)
- Casale Donn, President and CEO
- Smith Margaret Ekins, Chief Commercial Officer
- RA CAPITAL MANAGEMENT, L.P., Director
- Shah Pratik, Director
- Kelly Michael, Director
- Islam Saqib, Director